INBRX-109
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INBRX-109, covering 2026-01-09 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas [Phase 1]